Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1969 2
1970 5
1972 8
1973 9
1974 3
1975 11
1976 6
1977 7
1978 7
1979 4
1980 8
1981 3
1982 1
1983 1
1984 1
1986 3
1987 4
1988 3
1989 1
1990 4
1991 3
1992 1
1995 1
1998 1
1999 2
2000 2
2001 2
2002 4
2005 1
2009 2
2011 2
2013 1
2014 1
2015 3
2016 2
2017 3
2018 1
2019 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, Delman KA, Spitler LE, Puzanov I, Agarwala SS, Milhem M, Cranmer L, Curti B, Lewis K, Ross M, Guthrie T, Linette GP, Daniels GA, Harrington K, Middleton MR, Miller WH Jr, Zager JS, Ye Y, Yao B, Li A, Doleman S, VanderWalde A, Gansert J, Coffin RS. Andtbacka RH, et al. Among authors: spitler le. J Clin Oncol. 2015 Sep 1;33(25):2780-8. doi: 10.1200/JCO.2014.58.3377. Epub 2015 May 26. J Clin Oncol. 2015. PMID: 26014293 Clinical Trial.
Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O'Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA; BRIM-3 Study Group. Chapman PB, et al. N Engl J Med. 2011 Jun 30;364(26):2507-16. doi: 10.1056/NEJMoa1103782. Epub 2011 Jun 5. N Engl J Med. 2011. PMID: 21639808 Free PMC article. Clinical Trial.
Malignant melanoma.
Spitler LE. Spitler LE. J Invest Dermatol. 1976 Sep;67(3):435-41. doi: 10.1111/1523-1747.ep12514727. J Invest Dermatol. 1976. PMID: 787436 Free article. Review.
Transfer factor.
Spitler LE. Spitler LE. Int J Dermatol. 1978 Jul-Aug;17(6):445-58. doi: 10.1111/j.1365-4362.1978.tb06179.x. Int J Dermatol. 1978. PMID: 355164 Review. No abstract available.
Treatment of immune deficiency.
Fudenberg HH, Spitler LE, Levin AS. Fudenberg HH, et al. Among authors: spitler le. Am J Pathol. 1972 Dec;69(3):529-36. Am J Pathol. 1972. PMID: 4564039 Free PMC article. Review. No abstract available.
A repeating fast radio burst.
Spitler LG, Scholz P, Hessels JW, Bogdanov S, Brazier A, Camilo F, Chatterjee S, Cordes JM, Crawford F, Deneva J, Ferdman RD, Freire PC, Kaspi VM, Lazarus P, Lynch R, Madsen EC, McLaughlin MA, Patel C, Ransom SM, Seymour A, Stairs IH, Stappers BW, van Leeuwen J, Zhu WW. Spitler LG, et al. Nature. 2016 Mar 10;531(7593):202-5. doi: 10.1038/nature17168. Epub 2016 Mar 2. Nature. 2016. PMID: 26934226 Free article.
Immunotoxin therapy of malignant melanoma.
Spitler LE. Spitler LE. Med Oncol Tumor Pharmacother. 1986;3(3-4):147-52. doi: 10.1007/BF02934990. Med Oncol Tumor Pharmacother. 1986. PMID: 3543527 Review.
Immunologic approaches to the treatment of prostate cancer.
Harris DT, Matyas GR, Gomella LG, Talor E, Winship MD, Spitler LE, Mastrangelo MJ. Harris DT, et al. Among authors: spitler le. Semin Oncol. 1999 Aug;26(4):439-47. Semin Oncol. 1999. PMID: 10482186 Review.
Immunotherapy of coccidioidomycosis.
Catanzaro A, Spitler L, Moser KM. Catanzaro A, et al. Among authors: spitler l. J Clin Invest. 1974 Sep;54(3):690-701. doi: 10.1172/JCI107807. J Clin Invest. 1974. PMID: 4604574 Free PMC article.
128 results